Psoriatic arthritis (PsA) has been around for thousands of years. Archaeologists unearthed Egyptian mummies with signs of the disease. Back then, the treatments for swollen and painful joints and ...

There are several biosimilars available for biologics that may be used in psoriatic arthritis treatment, including several different ones for adalimumab, etanercept, and infliximab. And new ones ...

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar ...

This is very encouraging! There was further evidence that etanercept and ustekinumab were safer than adalimumab. Many patients with psoriatic arthritis are given disease modifying agents such as ...

The designation allows pharmacists to substitute it for Humira without prescriber approval (per state law), which expands ...

New study shows a subset of psoriatic arthritis patients can achieve long-term remission without DMARDs. Learn who benefits ...

HADLIMA™ (adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL is now interchangeable with all high- and low-concentration presentations ...

When you think of signs that something is amiss with your health, your first thought may be aches and pains or even visible issues like hair loss or skin flare ups. Your mind likely doesn't go to your ...

HADLIMA™ (adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL is now interchangeable with all high- and low-concentration presentations (autoinjector, prefilled syringe, and single-dose vial) of ...